| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $41.1M | — | +39.0% |
| SG&A Expense | $6.9M | — | -27.3% |
| Operating Income | -$48.0M | — | -23.0% |
| Pre-tax Income | -$45.4M | — | -33.2% |
| Income Tax | $50K | — | -75.4% |
| Net Income | -$45.4M | — | -32.6% |
| EPS (Basic) | -$0.57 | — | -42.5% |
| EPS (Diluted) | -$0.57 | — | -42.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $79.3M | -17.1% | -33.6% |
| Current Assets | $263.2M | -15.4% | -39.3% |
| Total Assets | $267.1M | -15.3% | -39.3% |
| Current Liabilities | $33.4M | -16.1% | +53.4% |
| Stockholders' Equity | $233.7M | -15.1% | -43.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$46.4M | — | -51.8% |
| Investing Cash Flow | $29.7M | — | -65.3% |
| Financing Cash Flow | $257K | — | +174.1% |